Decrease in vascular endothelial growth factor expression area in islets may be associated with type 2 diabetes development

Yoshihiro Takamiya, Yoichi Oikawa, Taketo Yamada, Akira Shimada, Hiroshi Itoh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: Animal studies have demonstrated that decreased vessel density in islets due to reduced expression of islet vascular endothelial growth factor (VEGF) may lead to impaired insulin secretion from β-cells, possibly contributing to type 2 diabetes development. However, no study has demonstrated an association between VEGF expression and vessel density in islets in human subjects with type 2 diabetes. The aim of this study was to evaluate the role of VEGF expression in islets in type 2 diabetes development, using human pancreatic tissue. Methods: We collected pancreatic tissue at autopsy from type 2 diabetic subjects (n = 13) and age- and sex-matched nondiabetic subjects (n = 13) under 80 years old, and investigated VEGF expression area and vessel density in islets by immunohistochemical staining. Results: In comparison with nondiabetic subjects, type 2 diabetic subjects showed a decrease in both islet VEGF expression area and islet vessel density, which were positively correlated in all subjects examined and in type 2 diabetic subjects. Conclusions: Decreased islet VEGF expression may be associated with the decrease in islet vessel volume, which probably contributes to type 2 diabetes development due to impaired insulin secretion from β-cells.

Original languageEnglish
Pages (from-to)202-208
Number of pages7
JournalDiabetology International
Volume3
Issue number4
DOIs
Publication statusPublished - 2012 Dec

Fingerprint

Type 2 Diabetes Mellitus
Vascular Endothelial Growth Factor A
Insulin
Human Development
Autopsy
Staining and Labeling

Keywords

  • Islet
  • Type 2 diabetes
  • Vascular endothelial growth factor (VEGF)
  • Vessel density

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Decrease in vascular endothelial growth factor expression area in islets may be associated with type 2 diabetes development. / Takamiya, Yoshihiro; Oikawa, Yoichi; Yamada, Taketo; Shimada, Akira; Itoh, Hiroshi.

In: Diabetology International, Vol. 3, No. 4, 12.2012, p. 202-208.

Research output: Contribution to journalArticle

Takamiya, Yoshihiro ; Oikawa, Yoichi ; Yamada, Taketo ; Shimada, Akira ; Itoh, Hiroshi. / Decrease in vascular endothelial growth factor expression area in islets may be associated with type 2 diabetes development. In: Diabetology International. 2012 ; Vol. 3, No. 4. pp. 202-208.
@article{52ea299a79154c099d8dd91c63460e56,
title = "Decrease in vascular endothelial growth factor expression area in islets may be associated with type 2 diabetes development",
abstract = "Aims: Animal studies have demonstrated that decreased vessel density in islets due to reduced expression of islet vascular endothelial growth factor (VEGF) may lead to impaired insulin secretion from β-cells, possibly contributing to type 2 diabetes development. However, no study has demonstrated an association between VEGF expression and vessel density in islets in human subjects with type 2 diabetes. The aim of this study was to evaluate the role of VEGF expression in islets in type 2 diabetes development, using human pancreatic tissue. Methods: We collected pancreatic tissue at autopsy from type 2 diabetic subjects (n = 13) and age- and sex-matched nondiabetic subjects (n = 13) under 80 years old, and investigated VEGF expression area and vessel density in islets by immunohistochemical staining. Results: In comparison with nondiabetic subjects, type 2 diabetic subjects showed a decrease in both islet VEGF expression area and islet vessel density, which were positively correlated in all subjects examined and in type 2 diabetic subjects. Conclusions: Decreased islet VEGF expression may be associated with the decrease in islet vessel volume, which probably contributes to type 2 diabetes development due to impaired insulin secretion from β-cells.",
keywords = "Islet, Type 2 diabetes, Vascular endothelial growth factor (VEGF), Vessel density",
author = "Yoshihiro Takamiya and Yoichi Oikawa and Taketo Yamada and Akira Shimada and Hiroshi Itoh",
year = "2012",
month = "12",
doi = "10.1007/s13340-012-0080-0",
language = "English",
volume = "3",
pages = "202--208",
journal = "Diabetology International",
issn = "2190-1678",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Decrease in vascular endothelial growth factor expression area in islets may be associated with type 2 diabetes development

AU - Takamiya, Yoshihiro

AU - Oikawa, Yoichi

AU - Yamada, Taketo

AU - Shimada, Akira

AU - Itoh, Hiroshi

PY - 2012/12

Y1 - 2012/12

N2 - Aims: Animal studies have demonstrated that decreased vessel density in islets due to reduced expression of islet vascular endothelial growth factor (VEGF) may lead to impaired insulin secretion from β-cells, possibly contributing to type 2 diabetes development. However, no study has demonstrated an association between VEGF expression and vessel density in islets in human subjects with type 2 diabetes. The aim of this study was to evaluate the role of VEGF expression in islets in type 2 diabetes development, using human pancreatic tissue. Methods: We collected pancreatic tissue at autopsy from type 2 diabetic subjects (n = 13) and age- and sex-matched nondiabetic subjects (n = 13) under 80 years old, and investigated VEGF expression area and vessel density in islets by immunohistochemical staining. Results: In comparison with nondiabetic subjects, type 2 diabetic subjects showed a decrease in both islet VEGF expression area and islet vessel density, which were positively correlated in all subjects examined and in type 2 diabetic subjects. Conclusions: Decreased islet VEGF expression may be associated with the decrease in islet vessel volume, which probably contributes to type 2 diabetes development due to impaired insulin secretion from β-cells.

AB - Aims: Animal studies have demonstrated that decreased vessel density in islets due to reduced expression of islet vascular endothelial growth factor (VEGF) may lead to impaired insulin secretion from β-cells, possibly contributing to type 2 diabetes development. However, no study has demonstrated an association between VEGF expression and vessel density in islets in human subjects with type 2 diabetes. The aim of this study was to evaluate the role of VEGF expression in islets in type 2 diabetes development, using human pancreatic tissue. Methods: We collected pancreatic tissue at autopsy from type 2 diabetic subjects (n = 13) and age- and sex-matched nondiabetic subjects (n = 13) under 80 years old, and investigated VEGF expression area and vessel density in islets by immunohistochemical staining. Results: In comparison with nondiabetic subjects, type 2 diabetic subjects showed a decrease in both islet VEGF expression area and islet vessel density, which were positively correlated in all subjects examined and in type 2 diabetic subjects. Conclusions: Decreased islet VEGF expression may be associated with the decrease in islet vessel volume, which probably contributes to type 2 diabetes development due to impaired insulin secretion from β-cells.

KW - Islet

KW - Type 2 diabetes

KW - Vascular endothelial growth factor (VEGF)

KW - Vessel density

UR - http://www.scopus.com/inward/record.url?scp=84871295370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871295370&partnerID=8YFLogxK

U2 - 10.1007/s13340-012-0080-0

DO - 10.1007/s13340-012-0080-0

M3 - Article

AN - SCOPUS:84871295370

VL - 3

SP - 202

EP - 208

JO - Diabetology International

JF - Diabetology International

SN - 2190-1678

IS - 4

ER -